The medical world is changing, and prioritizing patient comfort, experience and care is one of the main transformations ...

A clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa and published in the New England Journal of Medicine illustrates a powerful and efficient approach for comparing ...

Normally, hospitals are, well, flush with IV fluids. But right now, that isn’t the case. In addition to the physical damage to many hospitals and clinics in the region, Hurricane Helene knocked out ...

If you've been at a large public event like a triathlon or marathon recently, you may have noticed booths set up to provide athletes with IV infusions, promising fast rehydration or immune-boosting ...

Real-time customized precision combination therapies based on potential actionability and coalterations to provide therapeutic opportunities for hyperprogressive disease after immune checkpoint ...

Anti-TNFR2 monoclonal antibody LBL-019 in patients with advanced malignant tumors: A phase I, first-in-human, open-label, multicenter, dose escalation Study. This is an ASCO Meeting Abstract from the ...

Last week, the Australian Therapeutic Goods Administration added intravenous (IV) fluids to the growing list of medicines in short supply. The shortage is due to higher-than-expected demand and ...